首页> 外文OA文献 >Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

【2h】

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

机译：roltegrior药代动力学与ombalasvir，Paritaprevir / Ritonavir加入Dasbuvir的治疗方法，具有人类免疫缺陷病毒-1和丙型肝炎病毒繁殖：艾滋病临床试验组Sub-Chinal A5334S

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Charles S. Venuto; Yoninah S. Cramer; Susan L. Rosenkranz; Mark Sulkowski; David L. Wyles; Daniel E. Cohen; Jeffrey Schmidt; Beverly L. Alston‐Smith; Gene D. Morse;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s [J] . Charles S. Venuto, Yoninah S. Cramer, Susan L. Rosenkranz, British journal of clinical pharmacology . 2020,第1期

机译：roltegrior药代动力学与ombalasvir，Paritaprevir / Ritonavir加入Dasbuvir的治疗方法，具有人类免疫缺陷病毒-1和丙型肝炎病毒繁殖：艾滋病临床试验组Sub-Chinal A5334S
2. Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s [J] . Venuto Charles S., Cramer Yoninah S., Rosenkranz Susan L., British Journal of Clinical Pharmacology . 2020,第1期

机译：roltegrior药代动力学与ombalasvir，Paritaprevir / Ritonavir加入Dasbuvir的治疗方法，具有人类免疫缺陷病毒-1和丙型肝炎病毒繁殖：艾滋病临床试验组Sub-Chinal A5334S
3. Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses [J] . King Jennifer R., Khatri Amit, Trinh Roger, Antimicrobial agents and chemotherapy. . 2017,第2期

机译：每天携带ritonavir或inombatasvir / paritaprevir / ritonavir和dasbuvir的三次直接抗病毒方案给药一次或两次的药代动力学评估，用丙型肝炎和人类免疫缺陷病毒繁殖
4. Molecular Status of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus among Transgender Commercial Sex Workers in Surakarta, Indonesia [C] . Afiono Agung Prasetyo, Yulia Sari, Ruben Dharmawan, International Conference on Mathematics, Science, and Computer Science . 2017

机译：印度尼西亚苏克塔的逆床商业性交工作者乙型肝炎病毒，乙型肝炎病毒和丙型肝炎病毒的分子状况
5. Repurposing the Human Immunodeficiency Virus (HIV) Integrase Inhibitor Raltegravir for the Treatment of Felid Alphaherpesvirus 1 (FHV-1) Ocular Infection [D] . Pennington, Matthew Robert 2018

机译：重新利用人类免疫缺陷病毒（HIV）整合酶抑制剂Raltegravir来治疗猫疱疹病毒1（FHV-1）眼部感染
6. Raltegravir pharmacokinetics before and during treatment with ombitasvir paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s [O] . Charles S. Venuto, Yoninah S. Cramer, Susan L. Rosenkranz, 2020

机译：roltegrior药代动力学与ombalasvirParitaprevir / Ritonavir加入Dasbuvir的治疗方法具有人类免疫缺陷病毒-1和丙型肝炎病毒繁殖：艾滋病临床试验组Sub-Chinal A5334S
7. Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses [O] . Jennifer R. King, Amit Khatri, Roger Trinh, 2017

机译：每天携带ritonavir或植物免疫缺陷病毒的成年人和人类免疫缺陷病毒的成年人（Imbatasvir / Paritaprevir / Ritonavir和Dasbuvir）组合达伦韦或两次给予一次或两次的药代动力学评估

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

著录项

相似文献

相关主题

期刊订阅